A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case report
Abstract Background Metastatic cancer to the stomach is relatively rare. Prostate-specific antigen (PSA) is a reliable biomarker used in the screening and management of patients with prostate cancer. However, it is difficult to definitively diagnose a PSA-negative metastatic gastric tumor of prostat...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Japan Surgical Society
2020-12-01
|
Series: | Surgical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40792-020-01074-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839601291925389312 |
---|---|
author | Koji Shindo Kenoki Ohuchida Taiki Moriyama Fumio Kinoshita Yutaka Koga Yoshinao Oda Masatoshi Eto Masafumi Nakamura |
author_facet | Koji Shindo Kenoki Ohuchida Taiki Moriyama Fumio Kinoshita Yutaka Koga Yoshinao Oda Masatoshi Eto Masafumi Nakamura |
author_sort | Koji Shindo |
collection | DOAJ |
description | Abstract Background Metastatic cancer to the stomach is relatively rare. Prostate-specific antigen (PSA) is a reliable biomarker used in the screening and management of patients with prostate cancer. However, it is difficult to definitively diagnose a PSA-negative metastatic gastric tumor of prostate cancer because the cancer sometimes resembles primary gastric cancer in clinical images. It is also difficult to distinguish metastatic cancer from primary cancer even in the pathological examination of biopsy samples when the lesion is poorly differentiated adenocarcinoma. There is a possibility that the characteristics of the cancer are changed during treatment such as chemotherapy or radiation therapy. Therefore, careful consideration is required for surgical indication. Case presentation A 60-year-old male underwent radical prostatectomy and subsequent radiation therapy for advanced prostate cancer (pT3N1M0) 10 years previously, and hormone therapy was started for metachronous multiple bone metastasis 10 months before. Upper gastrointestinal endoscopy revealed an irregular depressed lesion with a convergence of folds at the greater curvature of the upper gastric body. Biopsy showed poorly differentiated adenocarcinoma that was negative for PSA upon immunohistochemistry. He had high serum carcinoembryonic antigen (CEA) (946.1 ng/ml) and carbohydrate antigen 19-9 (CA19-9) (465.1 U/ml) levels with no elevation of PSA (0.152 ng/ml). The tumor was diagnosed as primary gastric cancer based on the clinical imaging and pathological examination of the biopsy sample including the PSA staining. Based on the diagnosis, laparoscopic proximal gastrectomy with lymphadenectomy was performed. However, pathological examination of the resected specimen revealed poorly differentiated adenocarcinoma that was positive for other prostate markers such as androgen receptor. Thus, the patient was diagnosed with metastasized prostate cancer to the stomach. Conclusions We report a case of metastatic gastric cancer of prostate cancer 10 years after radical prostatectomy. In the present case, it was difficult to diagnose a metastatic gastric tumor of prostate cancer preoperatively, because of its resemblance to primary gastric cancer without PSA expression and no serum PSA elevation. Although a rare case entity, it is important to consider the possibility of a metastatic gastric tumor when the surgical indication is determined in cases with another co-existing cancer. |
format | Article |
id | doaj-art-6eac1844b9bb4cd0a6d78e4ceeddffab |
institution | Matheson Library |
issn | 2198-7793 |
language | English |
publishDate | 2020-12-01 |
publisher | Japan Surgical Society |
record_format | Article |
series | Surgical Case Reports |
spelling | doaj-art-6eac1844b9bb4cd0a6d78e4ceeddffab2025-08-02T10:36:55ZengJapan Surgical SocietySurgical Case Reports2198-77932020-12-01611710.1186/s40792-020-01074-7A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case reportKoji Shindo0Kenoki Ohuchida1Taiki Moriyama2Fumio Kinoshita3Yutaka Koga4Yoshinao Oda5Masatoshi Eto6Masafumi Nakamura7Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu UniversityDepartment of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu UniversityDepartment of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu UniversityDepartment of Urology, Kyushu University HospitalDepartment of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu UniversityDepartment of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu UniversityDepartment of Urology, Kyushu University HospitalDepartment of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu UniversityAbstract Background Metastatic cancer to the stomach is relatively rare. Prostate-specific antigen (PSA) is a reliable biomarker used in the screening and management of patients with prostate cancer. However, it is difficult to definitively diagnose a PSA-negative metastatic gastric tumor of prostate cancer because the cancer sometimes resembles primary gastric cancer in clinical images. It is also difficult to distinguish metastatic cancer from primary cancer even in the pathological examination of biopsy samples when the lesion is poorly differentiated adenocarcinoma. There is a possibility that the characteristics of the cancer are changed during treatment such as chemotherapy or radiation therapy. Therefore, careful consideration is required for surgical indication. Case presentation A 60-year-old male underwent radical prostatectomy and subsequent radiation therapy for advanced prostate cancer (pT3N1M0) 10 years previously, and hormone therapy was started for metachronous multiple bone metastasis 10 months before. Upper gastrointestinal endoscopy revealed an irregular depressed lesion with a convergence of folds at the greater curvature of the upper gastric body. Biopsy showed poorly differentiated adenocarcinoma that was negative for PSA upon immunohistochemistry. He had high serum carcinoembryonic antigen (CEA) (946.1 ng/ml) and carbohydrate antigen 19-9 (CA19-9) (465.1 U/ml) levels with no elevation of PSA (0.152 ng/ml). The tumor was diagnosed as primary gastric cancer based on the clinical imaging and pathological examination of the biopsy sample including the PSA staining. Based on the diagnosis, laparoscopic proximal gastrectomy with lymphadenectomy was performed. However, pathological examination of the resected specimen revealed poorly differentiated adenocarcinoma that was positive for other prostate markers such as androgen receptor. Thus, the patient was diagnosed with metastasized prostate cancer to the stomach. Conclusions We report a case of metastatic gastric cancer of prostate cancer 10 years after radical prostatectomy. In the present case, it was difficult to diagnose a metastatic gastric tumor of prostate cancer preoperatively, because of its resemblance to primary gastric cancer without PSA expression and no serum PSA elevation. Although a rare case entity, it is important to consider the possibility of a metastatic gastric tumor when the surgical indication is determined in cases with another co-existing cancer.https://doi.org/10.1186/s40792-020-01074-7Metastasized gastric cancerProstate cancerCEACA19-9PSA |
spellingShingle | Koji Shindo Kenoki Ohuchida Taiki Moriyama Fumio Kinoshita Yutaka Koga Yoshinao Oda Masatoshi Eto Masafumi Nakamura A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case report Surgical Case Reports Metastasized gastric cancer Prostate cancer CEA CA19-9 PSA |
title | A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case report |
title_full | A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case report |
title_fullStr | A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case report |
title_full_unstemmed | A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case report |
title_short | A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case report |
title_sort | rare case of psa negative metastasized prostate cancer to the stomach with serum cea and ca19 9 elevation a case report |
topic | Metastasized gastric cancer Prostate cancer CEA CA19-9 PSA |
url | https://doi.org/10.1186/s40792-020-01074-7 |
work_keys_str_mv | AT kojishindo ararecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT kenokiohuchida ararecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT taikimoriyama ararecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT fumiokinoshita ararecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT yutakakoga ararecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT yoshinaooda ararecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT masatoshieto ararecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT masafuminakamura ararecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT kojishindo rarecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT kenokiohuchida rarecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT taikimoriyama rarecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT fumiokinoshita rarecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT yutakakoga rarecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT yoshinaooda rarecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT masatoshieto rarecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport AT masafuminakamura rarecaseofpsanegativemetastasizedprostatecancertothestomachwithserumceaandca199elevationacasereport |